ADC THERAPEUTICS SA

Adc Therapeutics Slides 10% as Stock Falls Below 200‑Day SMA, Raising Investor Concerns

Adc Therapeutics drops 10%, trading at $1.44—below its 200‑day SMA and 52‑week high, raising liquidity worries and hinting at a potential correction.

ADC THERAPEUTICS SA
Switzerland
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

26/10/2026, 07:29

3 minutes to read

Adc Therapeutics Surges 5.56% as Investor Confidence Grows in ADC Platform

Adc Therapeutics jumps 35% month‑to‑date, fueled by a bullish 200‑day SMA and strong early‑stage oncology pipeline, enticing investors amid market volatility.

ADC THERAPEUTICS SA
Switzerland
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 22:09

3 minutes to read